Methadone-induced Torsade de pointes tachycardias

被引:0
|
作者
Sticherling, C
Schaer, BA
Ammann, P
Maeder, M
Osswald, S
机构
[1] Univ Basel Hosp, Div Cardiol, CH-4031 Basel, Switzerland
[2] Kantonsspital St Gallen, Div Cardiol, St Gallen, Switzerland
关键词
methadone; QT-prolongation; Torsade de pointes tachycardia;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methadone is a synthetic opioid frequently used in drug maintenance programs for heroin addicts. It prolongs the QT-interval and is mainly metabolized by the isoenzyme CYP3A4 of the hepatic cytochrome-P450-system, which is used by numerous other QT-prolonging agents. Its most severe side effect is the development of life-threatening Torsade de pointes ventricular tachycardia in the setting of a prolonged QT-interval. Since drug addicts are prone to concomitant medical conditions requiring additional medication as well as to continued abuse of cocaine, they are at higher risk for developing this major complication of methadone therapy. Before subjecting patients on methadone to other drugs, the QT-interval should be determined and it should be ascertained whether the new agent has the property to prolong the QT-interval or is metabolised by the cytochrome-P450 system.
引用
收藏
页码:282 / 285
页数:4
相关论文
共 50 条
  • [21] Torsade de pointes induced by ajmaline
    Haverkamp, W
    Mönnig, G
    Kirchhof, P
    Eckardt, L
    Borggrefe, M
    Breithardt, G
    ZEITSCHRIFT FUR KARDIOLOGIE, 2001, 90 (08): : 586 - 590
  • [22] DOXEPIN INDUCED TORSADE DE POINTES
    STRASBERG, B
    COELHO, A
    WELCH, W
    SWIRYN, S
    BAUERNFEIND, R
    ROSEN, K
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1982, 5 (06): : 873 - 877
  • [23] Itraconazole-induced Torsade de Pointes in a patient receiving methadone substitution therapy
    Robson, Noorzurani Md Haris
    Vicknasingam, Balasingam
    Narayanan, Suresh
    DRUG AND ALCOHOL REVIEW, 2009, 28 (06) : 688 - 690
  • [24] Cocaine-related Torsade de Pointes in a methadone maintenance patient
    Krantz, MJ
    Rowan, SB
    Mehler, PS
    JOURNAL OF ADDICTIVE DISEASES, 2005, 24 (01) : 53 - 60
  • [25] Haloperidol-induced torsade de pointes
    O'Brien, JM
    Rockwood, RP
    Suh, KI
    ANNALS OF PHARMACOTHERAPY, 1999, 33 (10) : 1046 - 1050
  • [26] Torsade de Pointes associated with very-high-dose methadone
    Krantz, MJ
    Lewkowiez, L
    Hays, H
    Woodroffe, MA
    Robertson, AD
    Mehler, PS
    ANNALS OF INTERNAL MEDICINE, 2002, 137 (06) : 501 - 504
  • [27] Torsade de Pointes Associated With Laxative Abuse in a Patient Receiving Methadone
    Laqueille, Xavier
    Genin, Christophe
    Pitrat, Benjamin
    Lupuyau, Aline
    Dervaux, Alain
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2013, 25 (04) : E24 - E24
  • [28] Drug-induced torsade de pointes
    Tamargo, J
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2000, 22 (06): : 389 - 390
  • [29] DRUG-INDUCED TORSADE DE POINTES
    RAEHL, CL
    PATEL, AK
    LEROY, M
    CLINICAL PHARMACY, 1985, 4 (06): : 675 - 690
  • [30] SIGNIFICANCE OF INDUCED TORSADE-DE-POINTES
    STRASBERG, B
    COELHO, A
    PALILEO, E
    BAUERNFEIND, R
    SWIRYN, S
    ROSEN, K
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1982, 5 (02): : 307 - 307